PRESS RELEASE: TECHLAB® Receives FDA 510(k) Clearance To Market E. HISTOLYTICA QUIK CHEK™ To Aid Clinicians In The Diagnosis Of Amebiasis Caused By The E. Histolytica Parasite
Read the full release here. BLACKSBURG, Va., June 13, 2017 /PRNewswire/ — TECHLAB®,® Inc., a leading developer and manufacturer of rapid, non-invasive diagnostic tests for gastrointestinal disease, today announced that it received U.S. Food and Drug Administration (FDA) clearance for E. HISTOLYTICA QUIK CHEK™ test. E. HISTOLYTICA QUIK CHEK™ test is the only rapid diagnostic test that specifically detects pathogenic E. histolytica and does not … Continue reading